One-time treatment of nex-z led to consistently rapid, deep and durable reduction in serum TTR through three years of follow-upConsistent trend ...
(HealthDay News) — Administration of nivolumab can cause adverse effects, including respiratory symptoms, according to a case study published in The Journal of Dermatology. Miri Yoshioka, from Chiba ...
Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...
Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes. Researchers at the University of Oxford, in collaboration with other researchers, ...
Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and ...
MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in ...
MedPage Today on MSN
Trial Patient Dies After Receiving CRISPR Gene Therapy
A patient with transthyretin amyloidosis (ATTR) who received the investigational gene therapy nexiguran ziclumeran (nex-z) in ...
The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR therapy nex-z has died. | The patient who was ...
Nex-z is the most closely watched drug in Intellia’s development pipeline. The company said in September that it planned to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback